Key result
IFN-γ-primed MSC-derived exosomes significantly improved cardiac function, promoted angiogenesis, and reduced apoptosis compared to control exosomes in a rat model of myocardial infarction.
Why the study?
Mesenchymal stromal cells activated with IFN-gamma show stronger physical effects, but whether exosomes derived from IFN-gamma-treated MSCs exert more potent cardioprotective effects against myocardial injury remained unclear.
p-value: p=<0.05
IFN-γ priming enhances the therapeutic efficacy of MSC-derived exosomes against acute myocardial infarction by upregulating miR-21, which targets BTG2 to promote angiogenesis and reduce apoptosis.
Hypothesis-generating for primed MSC exosomes in MI; human trials needed before any clinical consideration.
BACKGROUND: Mesenchymal stromal cells (MSCs) activated with IFN-γ elicit stronger physical effects. Exosomes (Exos) secreted from MSCs show protective effects against myocardial injury. This study aimed to determine whether Exos derived from IFN-γ-treated MSCs exhibit more potent cardioprotective function and the underlying mechanisms. METHODS: H9c2 cells or human umbilical vein endothelial cells (HUVECs) were treated with Exos isolated from MSCs (Ctrl-Exo) or IFN-γ-primed MSCs (IFN-γ-Exo) under oxygen and glucose deprivation (OGD) conditions in vitro and in vivo in an infarcted rat heart. RNA sequencing was used to identify differentially expressed functional transcription factors (TFs). Quantitative reverse transcription-PCR (qPCR) was used to confirm the upregulated TFs and miRNA in IFN-γ-primed MSCs. Dual-luciferase reporter gene assay was used to analyze the transcriptional regulation of miRNAs by STAT1. The target of miR-21-5p (miR-21) was determined by luciferase reporter assays and qPCR. The function of BTG2 was verified in vitro under OGD conditions. RESULT: IFN-γ-Exo accelerated migration and tube-like structure formation and prevented OGD-induced apoptosis in H9c2. Similarly, IFN-γ-Exo treatment caused a decrease in fibrosis, reduced cardiomyocyte apoptosis, and improved cardiac function compared to Ctrl-Exo treatment. MiR-21 was significantly upregulated in IFN-γ-primed MSCs and IFN-γ-Exo. STAT1 transcriptionally induced miR-21 expression. Up-regulated miR-21 could inhibit BTG anti-proliferation factor 2 (BTG2) expressions. BTG2 promoted H9c2 cell apoptosis and reversed the protective effects of miR-21 under OGD conditions. CONCLUSION: IFN-γ-Exo showed enhanced therapeutic efficacy against acute MI, possibly by promoting angiogenesis and reducing apoptosis by upregulating miR-21, which directly targeted BTG2.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied Myocardial infarction (n=24). IFN-γ-primed MSC-derived exosomes (IFN-γ-Exo) vs. Control MSC-derived exosomes (Ctrl-Exo) or PBS was evaluated on Cardiac function (LVEF and LVFS) and infarct area at 4 weeks (p=<0.05). IFN-γ-primed MSC-derived exosomes significantly improved cardiac function, promoted angiogenesis, and reduced apoptosis compared to control exosomes in a rat model of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: